(Q40353559)

19 September 2017

title

Decrease in motor performance in children with cancer is independent of the cumulative dose of vincristine (English)

1 reference

19 September 2017

4

Rob Pieters

1 reference

19 September 2017

Annelies Hartman

1

1 reference

19 September 2017

Cor van den Bos

series ordinal

2

1 reference

19 September 2017

Theo Stijnen

series ordinal

3

1 reference

19 September 2017

language of work or name

English

0 references

publication date

1 March 2006

1 reference

19 September 2017

1 reference

19 September 2017

volume

106

1 reference

19 September 2017

issue

6

1 reference

19 September 2017

page(s)

1395-1401

1 reference

Slight impairment of psychomotor skills in children after treatment of acute lymphoblastic leukemia.

19 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21706

Clinical neurological findings of children with acute lymphoblastic leukaemia at diagnosis and during treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21706

Long-term gross motor performance following treatment for acute lymphoblastic leukemia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21706

SIOP (International Society of Paediatric Oncology) and the management of Wilms' tumor

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21706

The role of preoperative chemotherapy in the management of Wilms' tumor. The SIOP studies. International Society of Pediatric Oncology

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21706

Vincristine therapy for children with acute lymphoblastic leukemia impairs conduction in the entire peripheral nerve

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21706

Transient posterior encephalopathy induced by chemotherapy in children.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21706

Intrathecal chemotherapy with antineoplastic agents in children

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21706

Osteonecrosis as a complication of treating acute lymphoblastic leukemia in children: a report from the Children's Cancer Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21706

Bony morbidity in children treated for acute lymphoblastic leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21706

Neurotoxicity secondary to antineoplastic drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21706

Microtubule behavior in the growth cones of living neurons during axon elongation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21706

The role of microtubule dynamics in growth cone motility and axonal growth

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21706

Vincristine neuropathy: neurophysiological and genetic studies in a case of Wilms tumor

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21706

21 January 2018

Vincristine revisited

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21706

7 January 2021

Retrospective study of intellectual development in children treated for acute lymphoblastic leukaemia

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21706

7 January 2021

Fine motor and handwriting problems after treatment for childhood acute lymphoblastic leukemia

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21706

7 January 2021

Limitation of ankle range of motion in survivors of acute lymphoblastic leukemia: a cross-sectional study

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21706

7 January 2021

Evolution of neuropathy and myopathy during intensive vincristine/corticosteroid chemotherapy for non-hodgkin's lymphoma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21706

7 January 2021

Full dose vincristine (without 2-mg dose limit) in the treatment of lymphomas

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21706

7 January 2021

High cure rate with a moderately intensive treatment regimen in non-high-risk childhood acute lymphoblastic leukemia. Results of protocol ALL VI from the Dutch Childhood Leukemia Study Group

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21706

7 January 2021

Reliability and concurrent validity of the movement assessment battery for children

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21706

7 January 2021

The use of glucocorticoids in acute lymphoblastic leukemia of childhood. Molecular, cellular, and clinical considerations.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21706

7 January 2021

Avascular necrosis of bone following an intensified chemotherapy regimen including high dose steroids

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21706

7 January 2021

Morphometric effects of vincristine on nerve regeneration in the rat

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21706

7 January 2021

Motor nervous system impairment persists in long-term survivors of childhood acute lymphoblastic leukemia

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21706

7 January 2021

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21706

7 January 2021

Vincristine treatment revealing asymptomatic hereditary motor sensory neuropathy type 1A

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21706

7 January 2021

Identifiers

DOI

10.1002/CNCR.21706

1 reference

19 September 2017

1 reference